GSK plc- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 GSK plc 公司

公司簡介

公司代碼GSK

公司名稱GSK plc

上市日期May 22, 1972

成立日期1999

CEOMs. Deborah Waterhouse

員工數量68629

證券類型Ordinary Share

年結日May 22

公司地址980 Great West Road

城市BRENTFORD

上市交易所London Stock Exchange

國家United Kingdom

郵編TW8 9GS

電話442080475000

網址https://www.gsk.com/

公司代碼GSK

上市日期May 22, 1972

成立日期1999

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Dr. Hal V. Barron, M.D.

Non-Executive Director

679.87K

+3.73%

Ms. Shobie Ramakrishnan

Chief Digital and Technology Officer

483.75K

+7.69%

Mr. Charles A. (Charlie) Bancroft

Senior Independent Non-Executive Director

31.40K

+0.44%

Dr. Jesse Goodman, M.D.

Non-Executive Independent Director, Scientific and Medical Expert

15.11K

+0.12%

Dr. Anne Beal

Independent Non-Executive Director

3.81K

+0.47%

Ms. Elizabeth McKee (Liz) Anderson

Independent Non-Executive Director

2.18K

+0.97%

Dr. Jeannie Lee

Independent Non-Executive Director

796.00

+0.76%

Mr. David S. Redfern

President - Corporate Development

--

Ms. Diana Conrad

Chief People Officer

--

Dr. Harry C. (Hal) Dietz

Independent Non-Executive Director, Scientific and Medical Expert

--

名稱

名稱/職務

職務

持股

持股變動

Dr. Hal V. Barron, M.D.

Non-Executive Director

679.87K

+3.73%

Ms. Shobie Ramakrishnan

Chief Digital and Technology Officer

483.75K

+7.69%

Mr. Charles A. (Charlie) Bancroft

Senior Independent Non-Executive Director

31.40K

+0.44%

Dr. Jesse Goodman, M.D.

Non-Executive Independent Director, Scientific and Medical Expert

15.11K

+0.12%

Dr. Anne Beal

Independent Non-Executive Director

3.81K

+0.47%

Ms. Elizabeth McKee (Liz) Anderson

Independent Non-Executive Director

2.18K

+0.97%

收入明細

單位: USD更新時間: 3月5日週三

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Respiratory

9.21B

22.98%

HIV

9.05B

22.59%

Shingles

4.29B

10.72%

Established Vaccines

4.26B

10.64%

Immuno-inflammation

4.21B

10.51%

Other

9.03B

22.53%

地區USD

名稱

營收

佔比

US

20.93B

52.21%

Rest of world

18.24B

45.52%

UK

904.52M

2.25%

業務

地區

業務USD

名稱

營收

佔比

Respiratory

9.21B

22.98%

HIV

9.05B

22.59%

Shingles

4.29B

10.72%

Established Vaccines

4.26B

10.64%

Immuno-inflammation

4.21B

10.51%

Other

9.03B

22.53%

股東統計

更新時間: 2月21日週五

持股股東

股東類型

持股股東

股東統計

佔比

Dodge & Cox

3.30%

Fidelity Management & Research Company LLC

2.11%

PRIMECAP Management Company

1.21%

JTC Employer Solutions Trusteee Ltd

0.97%

Fisher Investments

0.90%

Other

91.47%

持股股東

股東統計

佔比

Dodge & Cox

3.30%

Fidelity Management & Research Company LLC

2.11%

PRIMECAP Management Company

1.21%

JTC Employer Solutions Trusteee Ltd

0.97%

Fisher Investments

0.90%

Other

91.47%

股東類型

股東統計

佔比

Investment Advisor

8.92%

Investment Advisor/Hedge Fund

6.17%

Hedge Fund

0.95%

Research Firm

0.70%

Bank and Trust

0.08%

Holding Company

0.06%

Individual Investor

0.05%

Pension Fund

0.05%

Insurance Company

0.05%

Other

82.90%

機構持股

更新時間: 1月19日週日

報告期間

機構數

持股數

持股佔比

持股變動

2025Q1

1428

354.30M

17.09%

+26.99M

2024Q4

1481

355.05M

17.14%

+27.37M

2024Q3

1472

319.96M

15.44%

-30.07M

2024Q2

1585

322.06M

15.54%

-29.11M

2024Q1

1617

318.91M

15.39%

-23.51M

2023Q4

1614

299.80M

14.57%

-35.70M

2023Q3

1570

293.92M

14.35%

-37.45M

2023Q2

1545

286.57M

13.99%

-41.87M

2023Q1

1546

281.07M

13.72%

-55.01M

2022Q4

1546

286.90M

13.32%

-22.15M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

Dodge & Cox

68.44M

3.3%

+353.74K

+0.51%

Dec 31, 2024

Fidelity Management & Research Company LLC

43.77M

2.11%

+18.13M

+70.76%

Dec 31, 2024

PRIMECAP Management Company

25.26M

1.21%

+10.40M

+70.06%

Dec 31, 2024

JTC Employer Solutions Trusteee Ltd

20.27M

0.97%

-202.39K

-0.98%

Dec 31, 2024

Fisher Investments

18.83M

0.9%

+259.86K

+1.39%

Dec 31, 2024

Fidelity Institutional Asset Management

9.05M

0.43%

+5.67M

+168.16%

Dec 31, 2024

Goldman Sachs Asset Management, L.P.

8.85M

0.42%

+1.77M

+25.03%

Dec 31, 2024

T. Rowe Price International Ltd

7.56M

0.36%

+35.10K

+0.46%

Dec 31, 2024

State Street Global Advisors (US)

7.02M

0.33%

+247.17K

+3.64%

Dec 31, 2024

UBS Financial Services, Inc.

6.34M

0.3%

+5.68M

+871.38%

Dec 31, 2024

持股ETF

更新時間: 12 小時前

機構名稱

佔比

VanEck Pharmaceutical ETF

4.3%

Sound Equity Dividend Income ETF

3%

Keating Active ETF

2.96%

Brandes International ETF

2.71%

Altrius Global Dividend ETF

1.83%

Pacer Global Cash Cows Dividend ETF

1.75%

USCF Dividend Income Fund

1.73%

Fidelity Blue Chip Value ETF

1.29%

Fidelity Women's Leadership ETF

1%

Hartford Multifactor Diversified International ETF

0.78%

VanEck Pharmaceutical ETF

佔比4.3%

Sound Equity Dividend Income ETF

佔比3%

Keating Active ETF

佔比2.96%

Brandes International ETF

佔比2.71%

Altrius Global Dividend ETF

佔比1.83%

Pacer Global Cash Cows Dividend ETF

佔比1.75%

USCF Dividend Income Fund

佔比1.73%

Fidelity Blue Chip Value ETF

佔比1.29%

Fidelity Women's Leadership ETF

佔比1%

Hartford Multifactor Diversified International ETF

佔比0.78%

分紅派息

近5年累計派現 20.78B 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

Feb 05, 2025

GSK.NB Approximate interim Cash Dividend of gross USD 0.400652 paid on Apr 10, 2025 going ex on Feb 21, 2025

Feb 21, 2025

Apr 10, 2025

Feb 21, 2025

Oct 30, 2024

GSK.NB Final Cash Dividend of gross USD 0.376892 paid on Jan 09, 2025 going ex on Nov 15, 2024

Nov 15, 2024

Jan 09, 2025

Nov 15, 2024

Jul 31, 2024

GSK.NB Interim Cash Dividend of gross USD 0.392813 paid on Oct 10, 2024 going ex on Aug 16, 2024

Aug 16, 2024

Oct 10, 2024

Aug 16, 2024

May 01, 2024

GSK.NB Interim Cash Dividend of gross USD 0.384301 paid on Jul 11, 2024 going ex on May 16, 2024

May 17, 2024

Jul 11, 2024

May 16, 2024

Feb 01, 2024

GSK.NB Interim Cash Dividend of gross USD 0.404885 paid on Apr 11, 2024 going ex on Feb 22, 2024

Feb 23, 2024

Apr 11, 2024

Feb 22, 2024

Nov 01, 2023

GSK.NB Final Cash Dividend of gross USD 0.356356 paid on Jan 11, 2024 going ex on Nov 16, 2023

Nov 17, 2023

Jan 11, 2024

Nov 16, 2023

Jul 26, 2023

GSK.NB Interim Cash Dividend of gross USD 0.343532 paid on Oct 12, 2023 going ex on Aug 17, 2023

Aug 18, 2023

Oct 12, 2023

Aug 17, 2023

Apr 26, 2023

GSK.NB Interim Cash Dividend of gross USD 0.360944 paid on Jul 13, 2023 going ex on May 18, 2023

May 19, 2023

Jul 13, 2023

May 18, 2023

Feb 01, 2023

GSK.NB Interim Cash Dividend of gross USD 0.341883 paid on Apr 13, 2023 going ex on Feb 23, 2023

Feb 24, 2023

Apr 13, 2023

Feb 23, 2023

Nov 02, 2022

GSK.NB Final Cash Dividend of gross USD 0.334785 paid on Jan 12, 2023 going ex on Nov 17, 2022

Nov 18, 2022

Jan 12, 2023

Nov 17, 2022

拆合股

公告日期

類型

比率

Jun 24, 2022

Merger

5<4

Jun 24, 2022

Merger

5<4

Jun 24, 2022

Merger

5<4

Jun 24, 2022

Merger

5<4

公告日期

類型

比率

Jun 24, 2022

Merger

5<4

Jun 24, 2022

Merger

5<4

Jun 24, 2022

Merger

5<4

Jun 24, 2022

Merger

5<4

GSK plc

38.430USD

GSK plc

38.430

概覽

公司